Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121589) titled 'Clinical Study of 68Ga-Labeled EPHA2-Targeting Cyclic Peptide for PET/CT Imaging in Solid Tumors' on April 1.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: The First Hospital of Suzhou University

Condition: Advanced Solid Tumor

Intervention: Gold Standard: Pathologically confirmed EPHA2-positive solid tumor

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: Target condition:10;Difficult condition:0

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313445

D...